ATE489382T1 - Benzoxazinonderivate, deren herstellung und verwendung als arzneimittel - Google Patents

Benzoxazinonderivate, deren herstellung und verwendung als arzneimittel

Info

Publication number: ATE489382T1
Authority: AT; Austria
Prior art keywords: preparation; medicinal products; benzoxazinone derivatives; benzoxazinone; derivatives
Prior art date: 2002-04-09

Application number

AT03718741T

Other languages

English (en)

Inventor

Jover Antoni Torrens

Castrillo Perez Jose Aurelio

Constansa Jordi Frigola

Pria Josep Mas

Zueras Alberto Dordal

Fisas Escasany Maria Angeles

Original Assignee

Esteve Labor Dr

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-09

Filing date

2003-04-08

Publication date

2010-12-15

2003-04-08 Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr

2010-12-15 Application granted granted Critical

2010-12-15 Publication of ATE489382T1 publication Critical patent/ATE489382T1/de

Links

HQQTZCPKNZVLFF-UHFFFAOYSA-N 4h-1,2-benzoxazin-3-one Chemical class C1=CC=C2ONC(=O)CC2=C1 HQQTZCPKNZVLFF-UHFFFAOYSA-N 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Obesity (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Nutrition Science (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

AT03718741T 2002-04-09 2003-04-08 Benzoxazinonderivate, deren herstellung und verwendung als arzneimittel ATE489382T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200200813A ES2193875B2 (es)	2002-04-09	2002-04-09	Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
PCT/EP2003/003629 WO2003084952A1 (en)	2002-04-09	2003-04-08	Benzoxazinone-derived compounds, their preparation und use as medicaments

Publications (1)

Publication Number	Publication Date
ATE489382T1 true ATE489382T1 (de)	2010-12-15

Family

ID=28686085

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT03718741T ATE489382T1 (de)	2002-04-09	2003-04-08	Benzoxazinonderivate, deren herstellung und verwendung als arzneimittel
AT03712152T ATE316966T1 (de)	2002-04-09	2003-04-09	Benzoxazinonderivate, deren herstellung und deren verwendung als medikamente

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT03712152T ATE316966T1 (de)	2002-04-09	2003-04-09	Benzoxazinonderivate, deren herstellung und deren verwendung als medikamente

Country Status (28)

Country	Link
US (3)	US7056914B2 (de)
EP (2)	EP1497285B1 (de)
JP (1)	JP2005529866A (de)
KR (1)	KR20050008679A (de)
CN (1)	CN1659164A (de)
AR (2)	AR039256A1 (de)
AT (2)	ATE489382T1 (de)
AU (2)	AU2003222804A1 (de)
BR (1)	BR0309083A (de)
CA (1)	CA2481701A1 (de)
DE (2)	DE60335094D1 (de)
DK (1)	DK1500654T3 (de)
EC (1)	ECSP045353A (de)
ES (3)	ES2193875B2 (de)
HR (1)	HRP20040919A2 (de)
IL (1)	IL164442A0 (de)
IS (1)	IS7491A (de)
MA (1)	MA27692A1 (de)
MX (1)	MXPA04009889A (de)
NO (1)	NO20044322L (de)
NZ (1)	NZ536167A (de)
PL (1)	PL372537A1 (de)
PT (1)	PT1500654E (de)
RU (1)	RU2004133041A (de)
TN (1)	TNSN04203A1 (de)
UA (1)	UA79460C2 (de)
WO (2)	WO2003084952A1 (de)
ZA (1)	ZA200408275B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2193875B2 (es) *	2002-04-09	2005-03-01	Laboratorios Del Dr. Esteve, S.A.	Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
ES2222833B1 (es) *	2003-07-30	2006-03-01	Laboratorios Del Dr. Esteve, S.A.	Compuestos piperidinicos 1,4-disustituidos, su preparacion y su uso como medicamentos.
ES2228268B1 (es) *	2003-07-30	2006-07-01	Laboratorios Del Dr. Esteve, S.A.	Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
ES2228267B1 (es) *	2003-07-30	2006-07-01	Laboratorios Del Dr. Esteve, S.A.	Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
WO2005090340A1 (ja) *	2004-03-22	2005-09-29	Banyu Pharmaceutical Co., Ltd.	ピペリジン－１－カルボキサミド誘導体
US8147853B2 (en)	2005-02-15	2012-04-03	The Procter & Gamble Company	Personal care compositions containing hydrophobically modified non-platelet particles
WO2006102113A2 (en) *	2005-03-21	2006-09-28	The Procter & Gamble Company	Multi-phase personal care composition comprising visually distinct phases
US7820609B2 (en)	2005-04-13	2010-10-26	The Procter & Gamble Company	Mild, structured, multi-phase personal cleansing compositions comprising density modifiers
MX2007007312A (es) *	2005-04-13	2007-07-09	Procter & Gamble	Composiciones multifase estructuradas y suaves para la limpieza personal.
ITMI20050909A1 (it) *	2005-05-19	2006-11-20	Acraf	Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-
US20120015009A9 (en) *	2005-06-07	2012-01-19	The Procter & Gamble Company	Multi-phased personal care composition comprising a blooming perfume composition
ITMI20051523A1 (it) *	2005-08-03	2007-02-04	Acraf	Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo
EP1957374A2 (de) *	2005-12-08	2008-08-20	The Procter and Gamble Company	Ein nahe einer flächentopographie positioniertes etikett in der form umfassender behälter
EP1967519B1 (de) *	2005-12-28	2012-09-05	Japan Tobacco Inc.	3,4-dihydrobenzoxazin-verbindung und hemmer der vanilloid-rezeptor-typ1(vr1)-aktivität
US20070167338A1 (en) *	2006-01-09	2007-07-19	Mchugh Colin M	Multiphase personal care compositions comprising beads
US8104616B2 (en)	2006-02-11	2012-01-31	The Procter & Gamble Company	Clamshell package for holding and displaying consumer products
US8153144B2 (en) *	2006-02-28	2012-04-10	The Proctor & Gamble Company	Stable multiphase composition comprising alkylamphoacetate
CA2660799C (en) *	2006-08-14	2013-03-19	Council Of Scientific & Industrial Research	Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof
EP1902733A1 (de) *	2006-09-19	2008-03-26	Laboratorios Del Dr. Esteve, S.A.	Kombination von einem NMDA Rezeptorligand und einer Verbindung mit 5-HT6 Rezeptor-Affinität
CL2007003044A1 (es) *	2006-10-24	2008-07-04	Wyeth Corp	Compuestos derivados de benzoxazina; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y abuso o dependencia de sustancias entre otros.
US20090029900A1 (en) *	2007-07-27	2009-01-29	The Procter & Gamble Company	Personal care article for sequentially dispensing compositions with distinct fragrance characters
US20090028808A1 (en) *	2007-07-27	2009-01-29	The Procter & Gamble Company	Personal care article for sequentially dispensing compositions with variable concentrations of partitioned benefit or suspended benefit agents
US20090028809A1 (en) *	2007-07-27	2009-01-29	Jonathan Robert Cetti	Personal care article for sequentially dispensing compositions with variable concentrations of hydrophobic benefit materials
US7733945B2 (en) *	2008-03-18	2010-06-08	On-Ramp Wireless, Inc.	Spread spectrum with doppler optimization
US20090275574A1 (en) *	2008-05-05	2009-11-05	Astrazeneca Ab	Novel compounds-300
JP5642661B2 (ja) *	2009-03-05	2014-12-17	塩野義製薬株式会社	Ｎｐｙｙ５受容体拮抗作用を有するピペリジンおよびピロリジン誘導体
CN110684043B (zh) *	2019-08-13	2022-09-06	温州大学	一种c-n轴手性芳胺化合物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0714299B1 (de) *	1993-07-16	2002-04-24	Merck & Co. Inc.	Benzoxazinon- und Benzopyrimidinon- piperidinyl-Verbindungen als tokolytische Oxytocin-Rezeptor-Antagonisten
CA2187767A1 (en)	1994-04-14	1995-10-26	Joel R. Huff	Alpha1c adrenergic receptor antagonists
AU1328197A (en)	1995-12-01	1997-06-19	Synaptic Pharmaceutical Corporation	Aryl sulfonamide and sulfamide derivatives and uses thereof
AU7692996A (en)	1995-12-01	1997-06-27	Ciba-Geigy Ag	Receptor antagonists
WO1997025992A1 (en)	1996-01-16	1997-07-24	Merck & Co., Inc.	Tocolytic oxytocin receptor antagonists
EP0944388A4 (de)	1996-04-03	2001-08-16	Merck & Co Inc	Hemmern von farnesyl protein transferase
CA2273102A1 (en)	1996-12-03	1998-06-11	Banyu Pharmaceutical Co., Ltd.	Urea derivatives
WO1998035957A1 (en)	1997-02-14	1998-08-20	Bayer Corporation	Amide derivatives as selective neuropeptide y receptor antagonists
AU6309698A (en)	1997-03-12	1998-09-29	Banyu Pharmaceutical Co., Ltd.	Drugs containing aminopyridine derivatives as the active ingredient
US6187777B1 (en)	1998-02-06	2001-02-13	Amgen Inc.	Compounds and methods which modulate feeding behavior and related diseases
US6201025B1 (en)	1998-10-07	2001-03-13	Ortho-Mcneil Pharmaceutical, Inc.	N-aralkylaminotetralins as ligands for the neuropeptide Y Y5 receptor
WO2001007409A1 (en)	1999-07-23	2001-02-01	Astrazeneca Uk Limited	Carbazole derivatives and their use as neuropeptide y5 receptor ligands
CA2381111A1 (en)	1999-08-26	2001-03-01	Leah M. Giupponi	Npy antagonists: spiroisoquinolinone derivatives
SE9904652D0 (sv) *	1999-12-17	1999-12-17	Astra Pharma Prod	Novel Compounds
WO2001064675A1 (en)	2000-03-03	2001-09-07	Novartis Ag	Condensed thiazolamines and their use as neuropeptide y5 antagonists
WO2002094825A1 (en)	2001-05-22	2002-11-28	Banyu Pharmaceutical Co., Ltd.	Novel spiropiperidine derivative
HUP0401108A2 (hu) *	2001-08-07	2004-09-28	Banyu Pharmaceutical Co., Ltd.	Spirovegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ES2193875B2 (es) *	2002-04-09	2005-03-01	Laboratorios Del Dr. Esteve, S.A.	Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.

2002
- 2002-04-09 ES ES200200813A patent/ES2193875B2/es not_active Expired - Fee Related
2003
- 2003-04-04 US US10/407,343 patent/US7056914B2/en not_active Expired - Fee Related
- 2003-04-04 AR ARP030101184A patent/AR039256A1/es not_active Application Discontinuation
- 2003-04-08 PL PL03372537A patent/PL372537A1/xx not_active Application Discontinuation
- 2003-04-08 BR BR0309083-3A patent/BR0309083A/pt not_active IP Right Cessation
- 2003-04-08 DE DE60335094T patent/DE60335094D1/de not_active Expired - Lifetime
- 2003-04-08 MX MXPA04009889A patent/MXPA04009889A/es active IP Right Grant
- 2003-04-08 HR HR20040919A patent/HRP20040919A2/hr not_active Application Discontinuation
- 2003-04-08 RU RU2004133041/04A patent/RU2004133041A/ru not_active Application Discontinuation
- 2003-04-08 NZ NZ536167A patent/NZ536167A/en unknown
- 2003-04-08 ES ES03718741T patent/ES2356815T3/es not_active Expired - Lifetime
- 2003-04-08 IL IL16444203A patent/IL164442A0/xx unknown
- 2003-04-08 CN CN038128853A patent/CN1659164A/zh active Pending
- 2003-04-08 EP EP03718741A patent/EP1497285B1/de not_active Expired - Lifetime
- 2003-04-08 CA CA002481701A patent/CA2481701A1/en not_active Abandoned
- 2003-04-08 AT AT03718741T patent/ATE489382T1/de not_active IP Right Cessation
- 2003-04-08 JP JP2003582149A patent/JP2005529866A/ja active Pending
- 2003-04-08 KR KR10-2004-7016130A patent/KR20050008679A/ko not_active Withdrawn
- 2003-04-08 US US10/409,235 patent/US7041665B2/en not_active Expired - Fee Related
- 2003-04-08 AU AU2003222804A patent/AU2003222804A1/en not_active Abandoned
- 2003-04-08 AR ARP030101235A patent/AR048567A1/es not_active Application Discontinuation
- 2003-04-08 WO PCT/EP2003/003629 patent/WO2003084952A1/en not_active Ceased
- 2003-04-09 DK DK03712152T patent/DK1500654T3/da active
- 2003-04-09 PT PT03712152T patent/PT1500654E/pt unknown
- 2003-04-09 EP EP03712152A patent/EP1500654B1/de not_active Expired - Lifetime
- 2003-04-09 ES ES03712152T patent/ES2258219T3/es not_active Expired - Lifetime
- 2003-04-09 WO PCT/ES2003/000162 patent/WO2003084939A1/es not_active Ceased
- 2003-04-09 AU AU2003216934A patent/AU2003216934A1/en not_active Abandoned
- 2003-04-09 DE DE60303440T patent/DE60303440T2/de not_active Expired - Lifetime
- 2003-04-09 AT AT03712152T patent/ATE316966T1/de not_active IP Right Cessation
- 2003-08-04 UA UA20041109155A patent/UA79460C2/uk unknown
2004
- 2004-10-06 IS IS7491A patent/IS7491A/is unknown
- 2004-10-08 EC EC2004005353A patent/ECSP045353A/es unknown
- 2004-10-08 MA MA27902A patent/MA27692A1/fr unknown
- 2004-10-08 TN TNP2004000203A patent/TNSN04203A1/en unknown
- 2004-10-12 NO NO20044322A patent/NO20044322L/no not_active Application Discontinuation
- 2004-10-13 ZA ZA200408275A patent/ZA200408275B/en unknown
2006
- 2006-01-24 US US11/338,363 patent/US7514429B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7056914B2 (en)	2006-06-06
ES2356815T3 (es)	2011-04-13
HK1069820A1 (en)	2005-06-03
DK1500654T3 (da)	2006-06-06
ECSP045353A (es)	2005-01-28
AR048567A1 (es)	2006-05-10
MXPA04009889A (es)	2005-08-16
TNSN04203A1 (en)	2007-03-12
EP1500654A1 (de)	2005-01-26
PT1500654E (pt)	2006-06-30
BR0309083A (pt)	2005-04-19
UA79460C2 (en)	2007-06-25
HRP20040919A2 (en)	2005-04-30
CA2481701A1 (en)	2003-10-16
IL164442A0 (en)	2005-12-18
US20060128701A1 (en)	2006-06-15
EP1497285B1 (de)	2010-11-24
US7041665B2 (en)	2006-05-09
US20040067941A1 (en)	2004-04-08
WO2003084952A1 (en)	2003-10-16
AU2003216934A1 (en)	2003-10-20
DE60335094D1 (de)	2011-01-05
ES2258219T3 (es)	2006-08-16
PL372537A1 (en)	2005-07-25
DE60303440D1 (de)	2006-04-13
US7514429B2 (en)	2009-04-07
AU2003222804A1 (en)	2003-10-20
AR039256A1 (es)	2005-02-16
IS7491A (is)	2004-10-06
DE60303440T2 (de)	2006-10-26
ATE316966T1 (de)	2006-02-15
EP1497285A1 (de)	2005-01-19
NO20044322L (no)	2004-10-12
RU2004133041A (ru)	2005-09-10
US20040058920A1 (en)	2004-03-25
JP2005529866A (ja)	2005-10-06
WO2003084939A1 (es)	2003-10-16
NZ536167A (en)	2006-06-30
MA27692A1 (fr)	2006-01-02
EP1500654B1 (de)	2006-02-01
ES2193875B2 (es)	2005-03-01
ES2193875A1 (es)	2003-11-01
ZA200408275B (en)	2006-04-26
KR20050008679A (ko)	2005-01-21
CN1659164A (zh)	2005-08-24

Legal Events

Date	Code	Title	Description
2011-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE489382T1 (de)	2010-12-15	Benzoxazinonderivate, deren herstellung und verwendung als arzneimittel
DE50312295D1 (de)	2010-02-11	8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel
DE50209483D1 (de)	2007-03-29	Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
ATE469152T1 (de)	2010-06-15	Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel
ATE425979T1 (de)	2009-04-15	Neue substituierte imidazo-pyridinone und imidazo-pyridazinone, ihre herstellung und ihre verwendung als arzneimittel
ATE522213T1 (de)	2011-09-15	Fünfgliedrige-heteroringderivate , ihre herstellung und ihre verwendung als arzneimittel
DE59907961D1 (de)	2004-01-15	Indeno-, naphtho- und benzocyclohepta-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
DE60336907D1 (de)	2011-06-09	Spirobifluorenderivate, deren herstellung und deren verwendung
ATE524178T1 (de)	2011-09-15	Acylierte, heteroaryl-kondensierte cycloalkenylamine und deren verwendung als arzneimittel
DE50015711D1 (de)	2009-09-24	In 6-stellung substituierte indolinone, ihre herstellung und ihre verwendung als arzneimittel
DE60209779D1 (de)	2006-05-04	Sulfonamidderivate, deren herstellung und deren verwendung als medikamente
DE60318188D1 (de)	2008-01-31	Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
DE602005006815D1 (de)	2008-06-26	2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung
DE60323754D1 (de)	2008-11-06	Dioxan-2-alkylkarbamaten derivaten, deren herstellung und deren therapeutischen verwendung
DE602005002470D1 (de)	2007-10-25	1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
DE50003761D1 (de)	2003-10-23	Indeno-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
ATE420072T1 (de)	2009-01-15	Neue alkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel
ATE357448T1 (de)	2007-04-15	Benzoxazinonderivative, deren herstellung und verwendung
DE60208044D1 (de)	2006-01-19	Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
ATE323694T1 (de)	2006-05-15	Cyanoanthranylamid-derivate und deren verwendung als arzneimittel
ATE491710T1 (de)	2011-01-15	2-substituierte phenyl-5,7-dialkyl-3,7- dihydropyrrolä2,3-dü pyrimidin-4-onderivate, deren herstellung und pharmazeutische verwendung
DE602004015600D1 (de)	2008-09-18	Neue imidazolderivative, deren herstellung und deren verwendung als medikament
DE60012750D1 (de)	2004-09-09	Neue xanthon derivate, deren herstellung und verwendung als arzneimittel
ATE417846T1 (de)	2009-01-15	Aminotropanderivate, deren herstellung und deren therapeutische verwendung
DE602004028160D1 (de)	2010-08-26	(4-phenylpiperazin-1-yl)acylpiperidinderivate, deren herstellung und deren verwendung in therapeutka